World Top 500 Companies by Net Income as of 2023
- Rank by Revenue in Search Criteria: 8051Annual Revenue in USD: 1,874 Million USDAnnual Net Income in USD: -226 Million USDAnnual Results for Period Ending: For year ending December-2025World Rank (Jul-30-2023): 6,602Market Cap (Jul-30-2023): 2 Billion USDEmployee Count: 3,282Employee Count as of Date: As on December 2021Company Profile:Compass Diversified is a Publicly Traded Investment and Holding company. The company has annual revenue is 1.5 billion USD and having more than 4000 employees. It owns controlling interests in subsidiary businesses which maximizes operating flexibility and drives long term value creation. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8052Annual Revenue in USD: 75 Million USDAnnual Net Income in USD: -227 Million USDAnnual Results for Period Ending: For year ending December-2021World Rank (Jul-30-2023): 9,904Market Cap (Jul-30-2023): Employee Count: 218Employee Count as of Date: As on 2020Company Profile:Zogenix is a Pharmaceutical company. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8053Annual Revenue in USD: 3,543 Million USDAnnual Net Income in USD: -228 Million USDAnnual Results for Period Ending: For year ending December-2025World Rank (Jul-30-2023): 9,719Market Cap (Jul-30-2023): 1 Billion USDEmployee Count: Employee Count as of Date: Company Profile:Advantage Solutions is the promotions and advertising agency, leveraging deep understanding of manufacturer, retailer and media company. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8054Annual Revenue in USD: 1,193 Million USDAnnual Net Income in USD: -230 Million USDAnnual Results for Period Ending: For year ending March-2026World Rank (Jul-30-2023): 7,800Market Cap (Jul-30-2023): 1 Billion USDEmployee Count: 2,651Employee Count as of Date: As on 2021Company Profile:Columbus McKinnon Corporation is a Lifting and Smart Motion Control Technology company. It is having products in more than 50 countries and 16 brands across the globe. The company annual revenue is 809 million USD and 3,128 employees as on 2019. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8055Annual Revenue in USD: 1,188 Million USDAnnual Net Income in USD: -231 Million USDAnnual Results for Period Ending: For year ending December-2025World Rank (Jul-30-2023): 2,528Market Cap (Jul-30-2023): 6 Billion USDEmployee Count: 753Employee Count as of Date: As on 2020Company Profile:
Beijing Kunlun Tech is the leading Internet platform overseas enterprise company. As of the first half of 2022, the global average monthly active users reach 400 million. It has formed five major businesses including Overseas information distribution and metaverse platform Opera, Overseas social entertainment platform StarX, Global mobile game platform Ark Games, Leisure and entertainment platform and equity investment Kunlun Capital. The headquarters is in China.
Beijing Kunlun Tech was renamed to Kunlun Tech Co. Ltd in 2021.
- Rank by Revenue in Search Criteria: 8056Annual Revenue in USD: 1,268 Million USDAnnual Net Income in USD: -231 Million USDAnnual Results for Period Ending: For year ending December-2025World Rank (Jul-30-2023): 4,927Market Cap (Jul-30-2023): 3 Billion USDEmployee Count: 3,000Employee Count as of Date: As on September 2020Company Profile:
Curaleaf Holdings is a Cannabis company. Curaleaf has a presence in 23 states, owns and operates 101 dispensaries, 23 cultivation sites, and 30 processing sites with a focus on highly populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8057Annual Revenue in USD: 4,715 Million USDAnnual Net Income in USD: -232 Million USDAnnual Results for Period Ending: For year ending December-2025World Rank (Jul-30-2023): 2,569Market Cap (Jul-30-2023): 6 Billion USDEmployee Count: 9,000Employee Count as of Date: As on 2022Company Profile:
ELANCO ANIMAL HEALTH is a pharmaceutical company related to animal health care. It develops, manufactures, and markets products for companion and food for animals. The main product of the company is pharmaceutical drugs for animals. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8058Annual Revenue in USD: 4,276 Million USDAnnual Net Income in USD: -232 Million USDAnnual Results for Period Ending: Jun-2023 ending periodWorld Rank (Jul-30-2023): 1,886Market Cap (Jul-30-2023): 9 Billion USDEmployee Count: 19,000Employee Count as of Date: As on 2022Company Profile:
CATALENT is Pharmaceutical company with headquarters is in New Jersey, USA.Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world.CATALENT manufacture oral, sterile and inhaled dose forms, produce biologics for pre-clinical and clinical studies.CATALENT pharmaceutical industry in the development and manufacturing of new treatments for patients worldwide.
As on 2021, CATALENT has 19,000 employees
CATALENT annual revenue generated for period ending Jun-2022 was 4,828 million USD.
- Rank by Revenue in Search Criteria: 8059Annual Revenue in USD: 329 Million USDAnnual Net Income in USD: -236 Million USDAnnual Results for Period Ending: Dec-2022 ending yearWorld Rank (Jul-30-2023): 3,630Market Cap (Jul-30-2023): 4 Billion USDEmployee Count: 496Employee Count as of Date: As on 2021Company Profile:
Amicus Therapeutics is a Biotechnology company. The headquarters is in USA.
- Rank by Revenue in Search Criteria: 8060Annual Revenue in USD: 31 Million USDAnnual Net Income in USD: -237 Million USDAnnual Results for Period Ending: For year ending December-2021World Rank (Jul-30-2023): 3,662Market Cap (Jul-30-2023): 4 Billion USDEmployee Count: 250Employee Count as of Date: As on 2021Company Profile:
Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Headquarters is in USA.
Turning Point develops kinase inhibitors, a class of targeted cancer drugs, that are designed to bind to cancer cells with greater precision and affinity than existing therapies.
Bristol Myers Squibb has acquired Turning Point Therapeutics for 4.1 billion USD in an all-cash transaction and completed the transaction in 2022.